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ABSTRACT 
The Centers for Disease Control and Prevention (CDC) recommends chlamydia screening in 
young women and others who are at risk based on scientific evidence related to the effectiveness 
of screening to prevent chlamydial infection. Female patients may visit the emergency 
department (ED) with symptoms such as urethritis, abdominal pain, or vaginal spotting. For men, 
most complaints are urinary problems, discharge from the penis, and testicular pain. However, 
most infected patients are never symptomatic and have no abnormal physical findings. 
Therefore, the question that spurred this project was, “Why aren’t asymptomatic patients 
screened more often?” Furthermore, “Why are the CDC screening guidelines for chlamydia often 
not followed by providers?” The purpose of this evidence-based project was to provide an 
educational intervention to health care providers in the Emergency Department (ED) about the 
CDC guidelines for chlamydia screening and to encourage them to screen eligible asymptomatic 
patients in a Bronx community-based ED. As a result of the educational intervention, there was a 
significant improvement of the ED providers’ knowledge of the CDC guidelines; however, the 
screening rate remained low. During the period after the educational intervention, the ED 
participants did not satisfactorily comply with the CDC guidelines; however, ED participants 
consistently demonstrated their willingness to perform the chlamydia screening for eligible 
patients. This finding indicates a need for frequent education on the CDC guidelines on the 
importance of chlamydia testing to effectively improve the screening rates.  
Keywords: chlamydial infection, chlamydia screening, emergency department 
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SECTION ONE: INTRODUCTION 
With the number of chlamydial infections increasing every year, the impact of the disease 
on society has become a great concern for public health care.  In 2017, the Centers for Disease 
Control and Prevention (CDC; 2017) reported 1.7 million active cases of chlamydia in the 
United States, an increase of 22% since 2013.  In 2013, the estimated direct lifetime cost of 
treatment for chlamydia and associated complications was $516.7 million (Owusu-Edusei et al., 
2013).  Two thirds of new chlamydial infections occur among younger persons aged 15–24 
years.  Females have nearly twice the rate of chlamydia as males (CDC, 2017).  Chlamydia is 
one of the most common diseases, but it is preventable.  Untreated chlamydial infections can 
lead to serious complications and potential long-term damage to a woman’s reproductive system.  
Chlamydial infection is a public health issue because it is associated with increased rates of 
transmission of and susceptibility to other sexually transmitted infections (STIs) such as syphilis, 
gonorrhea, human papillomavirus, and human immunodeficiency virus infection.  
The chlamydia rate in the Bronx, New York, has remained higher than other New York 
City boroughs.  According to the New York State Department of Health (2017), in 2017, the 
number of chlamydia cases per 100,000 people in the Bronx was 1127.9, while the number for 
Manhattan was 939.5, and 358 for Long Island.  In 2019, one emergency department (ED) in the 
Bronx found eight, 10, and 14 cases of chlamydial infection in March, April, and May, 
respectively.  Each year, the number of cases of chlamydial infection has increased at that 
hospital.  
The CDC (2017) guidelines recommend annual chlamydia screening of all sexually 
active women aged <25 years, as is screening of older women at increased risk for infection 
(e.g., those who have a new sex partner, more than one sex partner, a sex partner with concurrent 
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partners, or a sex partner who has a sexually transmitted infection.  All pregnant women aged 
<25 years and older pregnant women at increased risk should also be screened.  Screening of 
sexually active men should be considered in clinical settings with a high prevalence of chlamydia 
(e.g., adolescent clinics, correctional facilities, and STD clinics) or in populations with high 
burden of infection (e.g., men who have sex with men). 
Background 
Chlamydia trachomatis, also known as chlamydia, is the most common bacterial STI 
worldwide.  Chlamydia is transmitted from person to person during unprotected sexual contact 
with the vagina, penis, mouth, or anus of an infected sexual partner (CDC, 2017).  Many 
chlamydial infections are asymptomatic.  Screening can be the first strategy to early detection 
and treatment.  The prevalence of chlamydia varies with age, race, gender, ethnicity, and county, 
according to national chlamydia surveillance systems (CDC, 2017).  Risk factors for infection 
include new or multiple sex partners, a history of STIs, presence of another STI, and inconsistent 
condom use (Ghanem & Tuddenham, 2017).  
Chlamydia screening in women is conducted using urine, endocervical, or vaginal 
samples, while for men, the screening method of choice is a urine sample.  Screening for 
chlamydia in the rectum and pharynx can be performed in persons who are at risk for infection at 
those sites.  Chlamydia testing can be done in a doctor’s office, a community health clinic, the 
health department, or a local Planned Parenthood health center.   
The CDC (2017) recommends azithromycin as primary therapy for the treatment of 
uncomplicated genital chlamydial infections.  Single-dose therapy of one-gram oral azithromycin 
is the first choice of antibiotic for all patients, including pregnant women.  Sex partners of those 
infected should get treated to prevent re-infection of the original patient.  Untreated chlamydial 
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infections can lead to serious complications such as urethritis, cervicitis, pelvic inflammatory 
disease (PID), ectopic pregnancy, and potential long-term damage to a woman’s reproductive 
system, including infertility (Menon et al., 2015).  Untreated chlamydia in pregnant women can 
lead to an increased risk of preterm delivery (CDC, 2016), as well as ophthalmia neonatorum 
(conjunctivitis) and pneumonia in the newborn (CDC, 2017).  For men, chlamydial infection can 
cause urethritis, acute epididymitis, chronic prostatitis, reactive arthritis (CDC, 2017), and male 
infertility (Redgrove & McLaughlin, 2014). 
Problem Statement 
Even though chlamydia screening has improved over the past decade, lack of awareness 
of the CDC guidelines among health care providers is still an important concern.  The screening 
rates for Chlamydia trachomatis among young women who have no sexually transmitted disease 
(STD)-related symptoms in the ED remain low despite the recommendations of screening by the 
CDC.  
Currently, the rate of chlamydial infection in the Bronx is a growing problem.  The 
evidence shows that screening asymptomatic patients in the ED who meet the CDC criteria has 
been an effective method for reducing chlamydial infection. 
Purpose of the Project 
The purpose of this scholarly project was to increase providers’ understanding of the 
CDC guidelines for chlamydia screening and increase screening rates in asymptomatic patients 
in the ED.  The ED would be a good place for STD screening to identify undiagnosed infections, 
especially for those patients who meet the CDC criteria for screening and are currently 
asymptomatic. Testing in the ED will increase early identification and facilitate treatment of 
diagnosed patients and their sexual partners. 
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Clinical Question 
For health care providers located in an urban ED, does an educational intervention 
focusing on the CDC guidelines for screening for chlamydia, compared to current knowledge on 
screening, lead to increased overall knowledge and increased screening rates for chlamydia in 
asymptomatic patients in the ED? 
SECTION TWO: LITERATURE REVIEW 
Search Strategy 
The main search engines used were the Cumulative Index of Nursing and Allied Health 
Literature, PubMed, and ProQuest Nursing and Allied Health Database.  The key words searched 
were chlamydial infection, chlamydial screening, and emergency department.  The search was 
limited to full-text research studies, the English language, and the years 2013–2019.  The search 
strategy identified a total of 102 references, but the articles were narrowed based on the quality 
of the literature, relevance to alternative areas of screening, type of study, and published date.  
Ultimately, the search yielded 29 related articles which were used for the literature review.  
Critical Appraisal 
Each article was reviewed using a summary and synthesis tool and examined for levels of 
evidence according to Melnyk’s Level of Evidence (Melnyk & Fineout-Overholt, 2005).  The 
literature findings included systematic reviews, clinical practice guidelines, controlled trials, 
mixed-method studies, and observational studies which pertained to chlamydia testing and the at-
risk, uninsured population.  The CDC guidelines for screening of chlamydia are scientific, 
evidence-based recommendations developed by the workgroup’s research, a second independent 
panel of public health and clinical experts’ review, and other professional organizations (CDC, 
2015).  Explanations of the ratings and of the strength of evidence are given in Appendix A.  
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All studies included in the evidence table (Appendix A) were published in peer-reviewed 
literature.  The main purpose of most studies was to identify the prevalence of chlamydial 
infection in the young female population, assess providers’ understanding of the CDC guidelines 
for chlamydia screening, or increase screening rates in asymptomatic patients in EDs.  The 
majority of studies (n = 24, 82.8%) were conducted in the United States.  Several studies (n = 8, 
27.6%) reported data relating to EDs.  However, the results reported within the systemic reviews 
with meta-analyses were consistent with the data from the ED studies.  Studies have detailed the 
lack of translation of the CDC guidelines into clinical practice (Carlson, Tschann, 
Santibenchakul, Hurwitz, & Salcedo, 2017; Goyal, Witt, Hayes, Zaoutis, & Gerber, 2014).  
These studies were retrospective chart reviews, but they extensively discussed the importance of 
physicians’ adherence to the CDC guidelines.  Only three of the 26 randomized controlled trials 
(RCTs) reported that a similar intervention provided an effective outcome.  Sixteen studies 
provided detailed information for chlamydia prevalence within specific demographics (two level 
I and one level IV), physician nonadherence (two level V and one level IV), the relationships of 
chlamydia and PID and infertility (four level I and one level V), and interventions to increase 
screening (three level III, two level IV).  The CDC guidelines are significant because they are 
backed by evidence.  One RCT study conducted in France did not provide sufficient information 
about the findings because the research is still in progress.  Two studies had limited scientific 
methods which resulted in low quality. 
Synthesis 
Most chlamydial infections are asymptomatic in both women and men (CDC, 2015; 
Morhason-Bello et al., 2014).  Because of the resultant outcome of untreated chlamydia, the 
importance of effective STD screening to identify early chlamydial infection was evident in the 
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literature (Anaene, Soyemi, & Caskey, 2016; CDC, 2015).  These studies indicated that the 
screening for asymptomatic patients should become a standard in today’s evidence-based 
practice (EBP).  Screening offers an important and promising adjunct for patients’ sexual health.  
By screening, providers can be sure they are basing important treatment decisions on evidence 
and that they are providing the best care.  Clearly, implementation of asymptomatic STD 
screening would be a significant benefit to providers’ ability to detect and treat chlamydial 
infection, and screening would have a positive impact on patients’ quality of life.  
Untreated chlamydia and complications. Chlamydia trachomatis is the most common 
STD in the United States.  The actual number of chlamydial infections probably exceeds three 
million annually because of undetected and untreated infections associated with asymptomatic 
patients in most cases (Wiesenfeld, 2017).  People between 15 and 24 years of age have the 
highest reported rates of chlamydia, with these rates being higher in women than in men (CDC, 
2015).  Because of the significant impact of untreated chlamydial infection on reproductive 
systems, many studies of patients who are infected with chlamydia have shown long-term 
clinical sequelae of chlamydial infection in women including cervicitis, PID (Gottlieb, Xu, & 
Brunham, 2013), and infertility (Morhason-Bello et al., 2014). Tamarelle et al. (2017) found that 
the early screening and treatment for chlamydia in young women less than 25 years of age may 
reduce the incidence of PID.  A study by Morhason-Bello et al. (2015) showed a higher 
proportion of chlamydial infection in women with infertility secondary to a tubal blockage 
(20.5%).  These studies consistently demonstrate the need for routine chlamydia screening 
according to the CDC guidelines.  The identification of a chlamydial infection can make a 
difference in the quality of life experienced by infected women.  It is important for all providers 
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to comply with the CDC guidelines to prevent the serious impacts the infection can cause on 
patients’ health and reproductive systems. 
Lack of testing by providers. Chlamydia screening may be primarily a provider’s 
decision in clinical settings.  Pickett et al. (2018) found physicians to be inadequate in following 
CDC guidelines for sexually active adolescents in pediatric EDs.  The study sought to measure 
physician adherence to the CDC guidelines for specimen collection and testing for chlamydia 
with both symptomatic and asymptomatic female patients. A limitation to the study was that only 
22.3% of potential participants responded to a mailed survey, and it is possible that not all 
physicians were identified for inclusion in the survey.  The study concluded that the CDC 
guidelines for chlamydia testing for adolescents in the ED were not adhered by physicians.  
Many providers appeared to lack recognition of the value of screening (Gift & Hogben, 2016).  
In their studies, the authors discussed the significant need to implement chlamydia screening 
according to the CDC guidelines.  Despite the high prevalence of chlamydial infection in 
asymptomatic patients, such screening is not routinely performed due to lack of awareness of the 
CDC recommendations.  The screening should be recognized as important in clinical practice but 
is often not taken into account when providers determine which specific CDC guidelines apply to 
a given patient.  
Provider education. In a study by Operario et al. (2016), the authors identified that the 
educational effect of chlamydia screening was significantly related to decreased chlamydial 
reinfection.  Providers could benefit from more education on the screening guidelines and from 
knowing that appropriate populations can be screened in EDs for asymptomatic chlamydia, 
which could lead to the diagnosis and treatment of many people before complications become a 
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problem.  In an RCT by McNulty et al. (2013), the authors found that receiving educational 
interventions doubled providers’ chlamydia screening rates in practice over control practices. 
Screening in the ED. The demand for ED care is growing for reasons including serious 
medical problems, the number of patients who are uninsured or who use Medicaid (Gindi, Black, 
& Cohen, 2016), and limited access to primary care (Coster, Turner, Bradbury, & Cantrell, 
2017).  Jenkins, Zahnd, Kovach, and Kissinger (2013) studied the prevalence of 
Chlamydia/gonorrhea infection in ED patients by assessing the treatment and effect of ED 
screening.  Jenkins et al’s (2013) study was consistent with the other studies (Anaene et al., 
2016; Schneider, FitzGerald, Byczkowski, & Reed, 2016) in that they found that screening was 
cost-effective for high-risk populations. Kreisel, Flagg, and Torrone (2017) conducted a study of 
the trends in PID in ED visits.  Their study demonstrated a decrease in the diagnosis of PID in 
EDs during 2006–2013, but the number of females diagnosed in reproductive age remained high 
in the ED.  They also found that a certain vulnerable population such as low income, uninsured, 
and Medicaid visited the ED because of PID.  Therefore, the ED provides a window of 
opportunity for chlamydia screening.  
Increasing chlamydia screening. Increasing chlamydia screening is the best approach to 
detect chlamydial infection, reduce transmission, and decrease the risk of PID. Several 
interventions have been recommended to promote screening among the sexually active young 
population, including improving providers’ knowledge (McKee et al., 2018; McNulty et al., 
2013), targeted outreach (Badarane et al., 2019), education for behavior change (Baird & 
Merchant, 2014; McNulty et al., 2013; Phillipson, Gordon, Telenta, Magee, & Jansenn, 2015; 
Tibbits et al., 2018), rapid testing (Natoli et al., 2014; Rivard et al., 2016), and preferred methods 
of sampling such as self-collected specimens (Eaton et al., 2019; Lunny et al., 2015).  Providers’ 
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intention to provide chlamydia screening can be increased when their personal attitude of 
screening is motivated by a positive behavioral change.  
Conceptual Framework 
The Iowa Model of Evidence-Based Practice was used for this evidence-based scholarly 
project.  The steps of the Iowa Model include identifying triggers, forming a team, reviewing the 
literature, designing the practice change, implementing the practice change, and evaluating and 
disseminating the results (Iowa Model Collaborative, 2017).  Permission to use the Iowa Model 
conceptual framework was granted on July 22, 2019, by the University of Iowa Department of 
Nursing and a copy is provided in Appendix B. 
Identifying a trigger. The trigger for this EBP project was the prevalence of chlamydia 
in the Bronx community.  Statistics show in that 2017, there were 1127.9 cases of chlamydia per 
100,000 people in the Bronx, as compared to 939.5 cases in Manhattan and 358 cases in Long 
Island (New York State Department of Health, 2017).  Asymptomatic patients who meet the 
CDC criteria for chlamydia screening were not being offered screening in the Bronx ED. The 
project coordinator determined that screening asymptomatic eligible patients in the ED should 
become a priority among ED providers in an attempt to help decrease the overall chlamydia rate 
in the Bronx.  
Forming a team. Team development for this scholarly project began with identification 
of key stakeholders.  A team was formed in the ED, which included the project coordinator, ED 
physicians, and ED physician assistants (PAs) who ultimately participated in the EBP project.  
The project team coordinator and the scholarly project chair worked collaboratively to ensure the 
scholarly project utilized the most current evidence from the literature during development and 
implementation.  
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Reviewing the literature. The literature was collected and critically appraised by the 
project coordinator.  The project coordinator chose 29 research studies which analyzed the 
strengths and limitations of screening for chlamydia.  The evidence clearly showed that 
screening was needed in asymptomatic high-risk populations.  One of the keys to increasing 
screening was educating providers on the CDC screening guidelines and obtaining their buy-in to 
screen asymptomatic patients who presented to the ED with non-life-threatening conditions.  
Designing the practice change. After the review of the literature, the project coordinator 
decided to provide an educational intervention for the ED providers which concentrated on the 
CDC recommendations for screening for chlamydia.  This included the recommendation to 
provide screening for all eligible asymptomatic patients, which was a change in practice for all 
the ED providers.  Prior to and after the educational intervention, a questionnaire was given to 
the providers, and the results of the pre- and post-intervention questionnaires were compared to 
measure the change in providers’ knowledge. 
Implementing the practice change. After the ED provider educational intervention, the 
practice change was initiated in the ED for a 60-day period.  The project sought to increase the 
providers’ knowledge of the CDC screening guidelines for chlamydia and increase the chlamydia 
screening rates in asymptomatic patients who present to the ED for non-life-threatening 
conditions.  
Evaluating and disseminating the results. Results of the pre- and post-intervention 
questionnaires were compared by the project coordinator.  After the 60-day intervention, the 
project coordinator compared the screening rate of the intervention with the 60 days prior to the 
start of the intervention.  The results of the project will be shared with the ED provider staff at a 
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later time, and recommendations will be made for continued provider education and continued 
integration of the intervention into the providers’ practice. 
Summary 
Educating providers and implementing the CDC chlamydia screening guidelines for 
asymptomatic patients in the ED setting could decrease the overall rate of chlamydia in the 
Bronx community.  Recent literature points to providers’ lack of awareness of the CDC 
guidelines for chlamydia screening and the providers’ lack of recognition of the value of 
screening as two of the main reasons that patients are not being screened routinely.  Furthermore, 
the literature suggests a need for additional STD screening sites.  Several articles focused on the 
value of screening asymptomatic patients who meet the criteria for chlamydia screening when 
they present to the ED for other non-emergent conditions.  
 The literature review supports the need to educate providers on the CDC guidelines for 
chlamydia screening and to encourage screening of asymptomatic patients.  The purpose of this 
scholarly project was to increase ED providers’ awareness of the CDC guidelines about 
chlamydia screening and increase screening rates in asymptomatic patients in the ED. 
SECTION THREE: METHODOLOGY 
Project Design 
This evidence-based project utilized the Iowa Model for Evidence-Based Practice.  Using 
this model, an education intervention on the CDC screening guidelines for chlamydia was 
conducted and evaluated with a pilot intervention.  The data were interpreted via descriptive 
statistics at the end of the project.  
The purpose of this EBP project was to increase ED providers’ awareness of the CDC 
guidelines about chlamydia screening and improve screening rates in asymptomatic patients in 
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the ED.  The project coordinator conducted a pretest for ED providers and then provided an 
education intervention.  Immediately following the education intervention, the providers were 
given a posttest to determine if they had an increase in knowledge from the intervention.  A 
retrospective and prospective data analysis was conducted by the project coordinator, and the 
results were compared to determine if there was an increase in screening of asymptomatic 
patients per the CDC guidelines by the providers after the education intervention.  This EBP 
project used a prospective cohort design with a retrospective electronic medical record review to 
examine the association between an evidence-based educational intervention and adherence to 
guidelines. 
Measurable Outcomes 
After completion of the educational program on chlamydia screening guidelines, ED 
providers were expected to show an increase in knowledge about chlamydia screening.  This was 
expected to be evidenced by an increase in the post-test score.  
After completion of the chart audit, providers in an urban ED were expected to 
demonstrate an increase in screening for asymptomatic chlamydia according to the CDC 
guidelines.  This was expected to be evidenced by an increase in the 60 days after the education 
intervention compared to the previous 60 days screening. 
Setting and Population 
The evidence-based scholarly project was conducted in the ED of a Bronx hospital.  The 
ED is a Level III in the Bronx, NY. 29.7% of the population in the area lives below the poverty 
line, and the majority are women aged 25-34 years. The largest ethnic group living in poverty is 
Hispanic, followed by African American.  In 2015, 54,416 adults made visits to this ED.   A 
letter of support from the organization is provided in Appendix F.   
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During the pre-implementation phase of this scholarly project, the project coordinator 
researched and compared the chlamydia rates for all New York City boroughs and the rates at the 
Bronx ED.  Chlamydia rates among females 15–24 years of age as well as among non-Hispanic 
Black individuals were found to be high in the Bronx ED.  The staff from the hospital who 
participated in this project included all ED attending physicians, PAs, and one nurse 
practitioner—the project coordinator.  The providers were a variety of ages and were from a 
multicultural population composed of Caucasian, Hispanic, Asian, and other ethnicities.  They 
provide care to any patient coming into the ED without regard to age, race, ethnicity, gender, 
religion, or the ability to pay.  The providers see a variety of medical conditions which can range 
from abdominal pain, urinary tract infections, STIs, respiratory illnesses, cardiac problems, and 
neurologic problems. 
Ethical Considerations 
The project team (project coordinator and project chair) completed research ethics 
training to ensure protection of human subjects.  The Collaborative Institutional Training 
Initiative Certificate is provided in Appendix E.  Further, the project was submitted to and 
received approval from the Liberty University Institutional Review Board.  A copy of the 
approval letter is provided in Appendix G. After data were collected from patient’s charts, non-
identifying information about the patients was removed.  The forms were shredded once the data 
is extracted, and all the data collected will be kept for three years and then deleted.  Furthermore, 
no patient or provider information will be reported in any future presentations or publications.  
No consent form was required for the participants.  The data from participants will not be 
released.  
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Data Collection 
The providers participated in a pretest and posttest after the education intervention to test 
their knowledge and gather demographic information.  A retrospective audit was conducted for 
the 60 days prior to the provider education intervention to determine how many times 
asymptomatic patients who met the screening criteria were actually screened for chlamydia in 
the ED.  In addition, a prospective audit was conducted for the 60 days following the provider 
education intervention to determine the number of asymptomatic patients who were screened for 
chlamydia in the ED according to the CDC guidelines.  
Tools 
A pre-education questionnaire (Appendix C) and post-education questionnaire (Appendix 
D) were provided to all ED provider participants.  Demographic information from the ED 
providers was collected.  A relevant tool was not found in the literature search; therefore, the pre-
education questionnaire and post-questionnaire were modified from the study of Lorch et al. 
(2013) to reflect the purpose of this scholarly project.  Lorch et al. (2013) used a questionnaire to 
evaluate if annual chlamydia screening for 16- to 29-year-old patients in general practice can 
decrease chlamydial infection.  The contents of the created questionnaires for this project 
included ED providers’ demographics, chlamydia knowledge testing and management, and their 
barriers to screening. 
Intervention 
The intervention for this evidence-based project was based on the CDC guidelines for 
chlamydia screening. A PowerPoint presentation was used for the education intervention, which 
was approximately 30 minutes.  The intervention was conducted at the beginning of each shift 
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for one week in the conference room of the ED.  All ED providers were expected to attend the 
presentation.  
The number of chlamydia screenings for asymptomatic patients in the ED for 60 days 
prior to the provider education intervention was obtained to determine how many times 
asymptomatic patients who met the screening criteria were actually screened for chlamydia in 
the ED.  The pre-education questionnaire was provided to all ED provider participants to obtain a 
measure of their knowledge to the CDC guidelines for chlamydia screening prior to the 
education intervention.  After the provider education intervention, the post-education 
questionnaire was completed by the ED providers to assess knowledge gained from the 
education intervention.  The prospective audit was conducted for 60 days following the provider 
education intervention to determine the number of asymptomatic patients who were screened for 
chlamydia in the ED according to the CDC guidelines.  
Timeline 
 The proposal was finished on July 31, 2019, and the defense of the project proposal was 
presented on August 2, 2019, then approved by the Liberty University Institutional Review 
Board on August 7, 2019.  The project was conducted in the ED of a Bronx hospital and 
completed on October 27, 2019.  The statistical data was analyzed with SPSS on November 11, 
2019.  This project’s results and discussion were reviewed by chair on November 11, 2019.  The 
final defense will be scheduled after the chair approves the final scholarly project manuscript.  
The doctoral project will be submitted to the Scholars Crossings after the final defense.  
Feasibility Analysis 
 All ED participants were rewarded with a five-dollar gift voucher for the hospital 
cafeteria after the post-education questionnaire. 
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Data Analysis  
Measurable outcome 1. The project coordinator reviewed, compared, and analyzed the 
results of the pre-intervention questionnaire and the post-intervention questionnaire.  The project 
coordinator utilized SPSS to analyze the results.  A t test was conducted to determine if there was 
a statistically significant difference in the knowledge the providers gained from the educational 
intervention on the CDC guidelines for chlamydia screening.  
Measurable outcome 2. The project coordinator compared and analyzed the pre-
intervention number of asymptomatic chlamydia screenings with the number of post-intervention 
eligible asymptomatic chlamydia screenings.  The project coordinator utilized Excel to compare 
the results by determining a p value.  The results did not show a statistically significant 
difference between the pre-intervention and post-intervention screenings. 
SECTION FOUR: RESULTS 
The purpose of this scholarly project was to increase ED providers’ understanding of the 
CDC guidelines for chlamydia screening and increase screening rates in asymptomatic patients 
in the ED.  The ED is a good place for STD screenings to identify undiagnosed infections, 
especially among those with asymptomatic infections or at a higher risk due to their 
demographic.  This would be especially helpful in areas of the country where the rate of 
chlamydia is higher, such as the Bronx.  Testing of asymptomatic patients in the ED can increase 
early identification of infections and facilitate treatment of patients and their partners.  
Before the implementation of an ED provider educational intervention on the CDC 
screening guidelines for chlamydia, a 60-day chart review was conducted from July 12, 2019, 
until August 10, 2019.  The chart review was performed to determine the number of 
asymptomatic chlamydia screenings performed in the ED during that period.  Prior to and after 
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the provider educational intervention, a questionnaire was used to determine the providers’ level 
of knowledge on chlamydia screening. Sixty days following the ED provider educational 
intervention, a repeat chart review was conducted for asymptomatic chlamydia screening.  
A post-education intervention questionnaire (PEIQ) was also conducted with the ED 
providers to uncover any issues the providers had with screening asymptomatic patients for 
chlamydia (Appendix H). 
Descriptive Statistics 
Of the 27 Bronx ED participants, 12 were physicians, and 15 were PAs.  One participant 
declined to participate in the pre- and post-educational questionnaires.  Demographic information 
was obtained on age, gender, and years of ED experience. Demographic information can be 
found in Table 1.  
Table 1 
 Demographic Characteristics of ED Providers  
 Frequency Percent 
Age   
< 30 7 25.9 
30–49 15 55.6 
> 50 5 18.5 
Gender   
Male 9 33.3 
Female 18 66.7 
ED Experience   
< 2 years 5 18.5 
2–5 years 8 29.6 
 > 5 years                 14 51.9 
Note.  N = 27. 
Measurable Outcome 1 
After completion of the educational program on chlamydia screening guidelines, it was 
expected that the ED providers would show an increase in knowledge about chlamydia screening 
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between the pre-intervention questionnaire and the post-intervention questionnaire.  The 
educational intervention, utilizing the pre-intervention and post-intervention questionnaire, was 
conducted from August 11, 2019 until August 17, 2019.  Questions on the pre- and post-
intervention questionnaire focused on asymptomatic chlamydia infections in women, the age 
groups of women with the highest rates of infection, and the recommendation for annual 
screenings for sexually active women under 25 years of age.  The ED providers demonstrated a 
significant increase in total correct answers on the post-intervention questionnaire.  Question 1 
asked which age group had the highest rate of chlamydia, Question 2 asked whether chlamydia is 
asymptomatic in most women, and Question 3 asked whether annual screening is recommended 
for sexually active females under age 25.  The results of the questionnaires are presented in 
Table 2 
Correct Responses on the Pre-Educational Questionnaire and Post-Educational Questionnaire 
 Pretest  Posttest 
 n %  n % 
Question 1 18 66.7  27 100.0 
Question 2 22 81.5  27 100.0 
Question 3 19 70.4  27 100.0 
 
The pre-educational questionnaire scores and the post-educational questionnaire scores 
were compared utilizing a t test.  The results of the t test were p = 0.000, 0.000, and 0.001, 
respectively.  After the educational intervention, the ED providers’ knowledge about chlamydia 
and the CDC screening guidelines had remarkably improved for each question.  Measurable 
outcome 1 was achieved since the post-intervention questionnaires indicated that 100% of the 
ED providers were able to answer all three questions accurately.  
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Table 3 
 Relationships Between the Pre- and Post-Educational Intervention Questionnaires  
 Mean Std. Deviation t df Sig. (2-tailed) 
Pair 1 (Question 1) .444 .577 4.000 26 .000 
Pair 2 (Question 2) .407 .501 4.228 26 .000 
Pair 3 (Question 3) .444 .480 3.606 26 .001 
 
Measurable Outcome 2 
After completion of the educational intervention on chlamydia screening, it was expected 
that providers would demonstrate an increase in the rate of screening of asymptomatic patients 
according to the CDC screening guidelines.  The number of asymptomatic screenings was 
compared for the 60 days prior to the intervention and the 60 days after the intervention.  
The pre-intervention data were collected from July 12, 2019, until August 10, 2019. 
Chlamydia screening rate categories included high risk females older than 25 years, pregnant 
females of all ages, females 24 years and younger, high-risk males, and patients who were 
already screened in 2019.  In addition, data was collected for patients with a history of chlamydia 
infections in the category of high risk. No asymptomatic high-risk females 25 years of age and 
older or asymptomatic high-risk males were screened. 
Measurable outcome 2 was only partially met since the screening rate only increased 
from 0.88% to 6.62% over a two-month period and the screenings only occurred in females 24 
years of age and younger. 
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Table 4 
Total ED Patient Visits and Chlamydia Screening Categories 
 Pre-Intervention Post-Intervention 
 
n 
Screening 
rates (%) n 
Screening 
rates (%) 
Female 2,470  2,816  
Age 25+ 2,273  2,603  
High risk 239  237  
ED screened 128 53.60 121 51.10 
Already screened in 2019 52 21.80 48 20.30 
Age < 25 197  213  
Symptomatic 84  77  
ED screened 44 52.30 55 71.40 
Already screened in 2019 15 17.90 15 19.50 
Asymptomatic 114  136  
ED screened 1 0.88 9 6.62 
Already screened in 2019 24 21.10 34 25.00 
Male 2,117  2,202  
High risk 230  146  
ED screened 75 32.60 50 34.2 
Already screened in 2019 13 5.65 6 4.11 
Total 4,587  5,018  
 
Figure 1 
Screening Rates 
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Post-Intervention Survey and Results 
Since the screening rates for asymptomatic chlamydia after the intervention were not 
significantly improved, the project coordinator conducted a PEIQ to identify barriers to provider 
screening in hopes of establishing effective strategies for encouraging the ED providers to 
screen.  The results of the educational intervention post-questionnaire showed the providers 
knew the screening guidelines, and the PEIQ noted that all participants were aware of the CDC 
chlamydia screening guidelines that recommend at least annual screening of asymptomatic 
females younger than 25 years of age.  Despite these factors, screening was found to be low in 
the asymptomatic groups.  The PEIQ survey focused on barriers to screening for the providers.   
Twenty-three ED providers from the original group responded to the PEIQ.  The 
providers were asked about chlamydia screening practices and barriers to following the CDC 
guidelines in the ED for asymptomatic patients.  Of the 23 ED providers, four participants chose 
not to test patients who were asymptomatic in the ED because they felt the ED was not the right 
place to screen.  Three participants thought that gynecology or primary care clinics were more 
appropriate places for chlamydia screening.  Fifteen participants stated that they would screen 
asymptomatic patients for chlamydia according to the CDC guidelines.  
After the PEIQ survey, the chlamydia screening rates were reevaluated for two weeks.  
Five out of 36 eligible asymptomatic patients (12.9%) were screened in the Bronx ED during the 
two-week period following the PEIQ. 
SECTION FIVE: DISCUSSION 
Implication for Practice 
The goal of this scholarly project was to improve ED providers’ knowledge about 
chlamydia and the CDC screening guidelines for chlamydia and increase screening rates in 
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asymptomatic patients in the ED.  Clearly, there was a significant difference in the providers’ 
knowledge level between the pre- and post-implementation questionnaires after the provider 
education intervention.  The providers also indicated on their questionnaires a willingness to 
screen asymptomatic patients in the ED during an unrelated problem visit. 
Although scores on all the post-intervention questionnaires showed 100% provider 
awareness of the CDC guideline recommendations for chlamydia screening, chlamydia screening 
rates in the Bronx ED were not significantly improved in the two-month period following the 
intervention.  The screening rate did increase from 0.88% to 6.62% over the two-month period.  
All the screenings occurred in females 24 years of age and younger.  This finding was consistent 
with the findings of Keegan, Diedrich, and Peipert (2014), who reviewed literature on current 
criteria and the rationale for Chlamydia trachomatis screening and suggested that health 
practices were not following current screening recommendations satisfactorily. 
Chlamydia screening of asymptomatic eligible women increased in the two weeks 
following the PEIQ survey provided to the staff after the 60-day intervention period.  The 
purpose of this post-project survey was to identify ED provider barriers to screening 
asymptomatic eligible patients in the ED for chlamydia and to elicit strategies to assist the ED 
providers in screening their patients.  The findings confirm that despite provider knowledge of 
the screening guidelines for chlamydia, providers are reluctant to screen appropriate patients.  
Barriers to screening included the fact that some providers felt that the ED was not the 
appropriate place to screen asymptomatic patients and some providers felt that gynecology or 
primary care clinics were better screening sites.  Over half the providers surveyed reiterated that 
they would screen asymptomatic patients in the ED according to the CDC guidelines.  Clearly, 
the ED providers will continue to screen symptomatic patients that present to the ED.  The ED 
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providers’ new knowledge about chlamydia screening guidelines and the fact that over half of 
the providers are willing to screen asymptomatic patients is encouraging for future practice, and 
it is hoped that more than half the eligible patients coming into the ED will be screened for 
chlamydia in the future.  This would help make a difference in the higher-than-average 
chlamydia rates in the Bronx area. 
Patient factors that pose a higher risk for chlamydial infection include gender, age, and 
previous history of a chlamydia infection.  This EBP project sought to increase chlamydia 
screening in the eligible asymptomatic patient presenting to a Bronx ED.  To improve screening 
rates in the future, ED providers should have frequent educational updates on the CDC practices 
guidelines for screening for chlamydia.  In addition, provider perception was an identified barrier 
to asymptomatic chlamydia screening the Bronx ED.  Hopefully, with frequent provider 
education and reminder sessions this barrier and misconception will be minimized.  
Sustainability 
The goal of sustainability for this EBP project was for the Bronx ED staff to continually 
be aware of the CDC chlamydia screening guidelines, and if the opportunity arises in their 
practice, to screen any eligible asymptomatic patients for chlamydia.  The ED is an excellent 
place to consider screening for eligible asymptomatic patients who meet the CDC screening 
criteria.  Many patients who use the services of the ED either do not have a primary health care 
provider or are uninsured or low-income and have limited monetary resources.  Screening 
eligible patients in the ED would ultimately save the patient time and the community added 
medical costs.  Patients who are found positive would benefit from early treatment and may be 
able to avoid the long-term health consequences of a chlamydial infection.  Providers in the ED 
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and their patients need to realize that screening for chlamydia is as easy as obtaining a urine 
sample and only rarely would the patient need a pelvic examination.  
This EBP project affords an opportunity for NPs to be designated as leaders in ensuring 
that the ED providers keep current with the CDC recommendations for screening and continually 
encourage the other ED providers to test their high-risk asymptomatic patients.  The NPs could 
also be responsible for coordinating and initiating the testing on all eligible patients who come 
into the ED, regardless of the patient’s provider.  This service could help sustain the practice that 
was started by this scholarly project.  In addition, the NPs could be responsible for educating the 
patients 24 years of age and younger to help improve their knowledge of chlamydia and other 
STIs. 
Limitations 
Several limitations to the normal ED practice occurred during the implementation phase 
of this evidence-based project.  During this time the hospital changed their computer system.  
This caused many logistical problems for providers because they had to learn where to place 
their orders, and many providers had a difficult time opening the old computer system to view 
the patient’s previous medical history related to chlamydia infections.  
Although all of the ED providers who attended the educational intervention scored 100% 
on their post-educational questionnaire, there were some ED providers who expressed personal 
biases against testing asymptomatic eligible patients in the ED.  These biases included the 
thought that screening should be done at a gynecology or primary care office and not in the ED 
and the notion that the patient was not in the ED with that specific problem and should not be 
tested.  
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In addition, the pediatric ED saw many patients up to age 20 years during the project 
period.  Another limitation was that some ED providers were not available to participate in the 
educational intervention but saw ED patients during the post-intervention phase.  In the Bronx 
area, there are other community hospitals for the patients to use, which may have decreased the 
number of potential patients screened.   
Dissemination Plan 
This scholarly project will serve as an initiative for health care providers in the ED and 
other clinics including primary care, gynecology, and pediatrics.  The results of the project will 
be disseminated at the quality improvement meetings in the Bronx ED, which will include the 
specific data related to the result of the positive chlamydia test found during the post-educational 
intervention period in an asymptomatic female patient 24 years of age.  Additional dissemination 
will occur through presentations at conferences, such as NP education, PA education, and 
medical student education. 
Summary 
The goal of the project was to increase ED providers’ understanding of the CDC 
guidelines for chlamydia screening, increase screening rates in asymptomatic patients in ED, and 
provide early identification of chlamydial infections.  Although the goal of this evidence-based 
staff education intervention was to increase screening of asymptomatic eligible patients in the 
ED, the rate of improvement was only from 0.88% pre-intervention to 6.62% during the 60-day 
period after the education intervention.  Despite the screening rates not being significantly 
improved, the ED providers appreciated the opportunity to gain more knowledge and 
understanding about the CDC guidelines for chlamydia and about the high prevalence of 
chlamydia in the Bronx.  Through provider continuing education and reminder sessions, the 
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practice of screening asymptomatic eligible patients in the ED for chlamydia should become 
routine as providers see eligible asymptomatic patients for other non-life-threatening problems.  
In turn, this will ultimately help decrease the number of cases of chlamydia seen in the Bronx, 
New York.  
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Evidence Table 
Name: Mikyung Kim 
Clinical Question: In healthcare providers located in an urban ED, does an educational intervention focusing on the CDC 
guidelines for screening for chlamydia, as compared to current knowledge on screening, lead to increased overall knowledge and 
increased screening rates for chlamydia in asymptomatic patients in the ED? 
Author (year) Study 
Purpose/ 
Objective(s) 
Design, 
Sampling 
Method, & 
Subjects 
LOE Intervention & 
Outcomes 
Results Study 
Strengths & 
Limitations 
Would Use as 
Evidence to 
Support a 
Change? 
Anaene, M., Soyemi, K., 
& Caskey, R. (2016). 
Factors associated with 
the over-treatment and 
under-treatment of 
gonorrhea and chlamydia 
in adolescents presenting 
to a public hospital 
emergency department. 
International Journal of 
Infectious Diseases, 53, 
34-38. 
doi:10.1016/j.ijid.2016.1
0.009 
To evaluate 
the rates of 
STDs, the 
rates of over-
treatment 
(OT) and 
under-
treatment 
(UT) of 
STDs, and the 
factors related 
to OT and 
UT. 
797 patients 
aged 13-24 
screened for 
CT/GC in 
the 
emergency 
department 
(ED) of 
John H. 
Stronger 
Hospital in 
Cook 
county 
Level V  
 
A non-
experimental 
systemic, 
retrospective 
chart review 
 
21.6% showed 
positive of 
CT/GC. 21.6% 
was OT and 
43.4% was UT. 
Patients 
complaining 
with sexually 
transmitted 
infections 
exposure or GU 
symptoms were 
more likely to 
be OT.  
A single 
public 
hospital; the 
results may 
not 
generalize to 
all hospitals. 
No cause-
and-effect 
relationships 
 
Yes, the finding 
was well 
answered to the 
purpose of the 
study. The GC/CT 
rapid testing 
would decrease 
the OT/UT. 
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Badarane, D., Knox, J., 
Camacho, A., Magill, M. 
K., Van Hala, S., & 
Jones, J. L. (2019). 
Increasing chlamydia 
testing rates via targeted 
outreach. PRiMER,3(17). 
doi:10.22454/PRiMER.2
019.669190 
To assess 
effectiveness 
chlamydia 
screening QI 
interventions 
(patient 
targeted 
outreach) 
Average 
60.6 women 
per month 
during the 
2016-2017 
and 60.2 
women 
during 
2017-2018 
Level IV Prospective 
cohort study 
Outreach efforts 
increase 
chlamydia 
screening rates 
 
Small 
sample, 
single clinic 
 
Yes, successful 
intervention to 
target population 
can improve 
chlamydia 
screening and the 
QI project can be 
replicated to other 
clinical settings.  
Carlson, A. D.P., 
Tschann, M., 
Santibenchakul, S., 
Hurwitz, E. L., & 
Salcedo, J. (2017). 
Physician adherence to 
sexually transmitted 
infection screening 
guidelines in an 
OB/GYN teaching clinic 
in Hawai’i. Hawai’i 
Journal of Medicine and 
Public Health, 76(11), 
299-304. 
doi:10.1177/1524839918
769592  
 
To evaluate 
physicians 
adherence to 
STD 
screening 
guidelines and 
to determine 
demographic 
factors such 
as age group, 
race, 
insurance 
type, and visit 
type related to 
STD 
recommendati
ons among 
women 14–25 
years old 
446 patients Level V A retrospective 
chart review 
 
Demographic 
factors were 
influenced with 
a significant 
gap in physician 
adherence to 
STD screening 
guidelines 
(71.0% received 
screening 
recommendatio
ns). 
Single 
outpatient 
GYN clinic 
 
Yes, this study 
strengthened the 
importance of 
physician 
recommendations. 
 
Centers for Disease 
Control and Prevention. 
(2015). 2015 Sexually 
transmitted diseases 
treatment guidelines. 
To determine 
the CDC 
recommendati
ons for 
screening for 
Systematic 
literature 
review 
using an 
extensive 
Level I High quality 
prospective 
cohort study 
with systematic 
review 
The chlamydia 
is the most 
frequently 
reported 
infectious 
The 
recommenda
tions might 
be modified 
by the 
Yes. This CDC 
recommendations 
provide validity 
and reliability of 
the evidence 
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Retrieved from 
https://www.cdc.gov/std/
tg2015/screening-
recommendations.htm 
chlamydial 
infection and 
the supporting 
scientific 
evidence 
MEDLINE 
database 
diseases in the 
U.S. and 
prevalence is 
highest in 
persons aged 
less than 25 
years.  
certain 
population, 
prevalence, 
and 
providers’ 
perspective 
in the 
community 
utilization in 
chlamydia 
screening.  
Natoli, L., Maher, L., 
Shephard, M., Hengel, 
B., Tangey, A., Badman, 
S. G., . . . Guy, R. J. 
(2014). Point-of-care 
testing for chlamydia and 
gonorrhea: Implications 
for clinical practice. PloS 
One, 9(6), e100518. 
doi;10.1371/journal.pone
.0100518 
To assess 
whether 
routine point-
of –care 
(POC) testing 
for CT/GC is 
effective in 
remote 
settings. 
 
Purposive 
sampling 18 
participants 
 
Level VII Expert opinion Identified the 
POC testing 
needs 
management 
pathways to 
improve STDs 
care.  
 
Small 
sample size, 
no 
experiment 
study 
Yes, the POC 
testing would 
detect chlamydia 
for those 
asymptomatic 
people and 
provide better 
STDs care.  
Owusu-Edusei, K., 
Chesson, H. W., Gift, T. 
L., Tao, G., Mahajan, R., 
Ocfemia, M. C., & Kent, 
C. K. (2013). The 
estimated direct medical 
cost of selected sexually 
transmitted infections in 
the United States, 2008. 
Sexual Transmitted 
Disease, 40(3), 197-201. 
doi:10.1097/OLQ.0b013
e318285c6d2. 
To estimate 
the direct 
medical cost 
to sexually 
transmitted 
infections. 
 
No 
applicable 
Level V Decretive 
retrospective  
In 2008, 516.7 
million dollars 
costed for 
chlamydial 
infection. 
 
No 
intervention. 
Yes, the findings 
suggested the 
need of chlamydia 
prevention and 
management. 
Currently the total 
costs for the 
chlamydia would 
be even greater 
because of the 
growing 
chlamydia rates.  
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Gindi, R. M., Black, L. 
I., & Cohen, R. A. 
(2016). Reasons for 
emergency room use 
among U.S. adults aged 
18–64: National health 
interview survey, 2013 
and 2014. National 
Health Statistics Reports, 
90. Retrieved from 
https://www.cdc.gov/nch
s/data/nhsr/nhsr090.pdf 
 
To examine 
the factors 
associated 
with patient 
visit to the 
ED. 
 
National 
health 
interview 
survey from 
the 2013 
and 2014;  
26,825 
sample 
adults aged 
18-64 in 
2013 and 
28,053 aged 
10-64 in 
2014. 
Level V Descriptive 
retrospective 
review  
 
The choice of 
ED visit for 
adults was 
affected by their 
insurance type. 
Uninsured 
adults visited 
EDs more than 
private 
coverage adults. 
About 79.7% of 
adults visited 
ED because of 
lack of access to 
other providers. 
Possible 
interviewees
’ recall bias 
of the type 
of illness and 
insurance. 
Yes, the finding 
are consistent to 
our ED 
population. The 
data will be a 
good resource to 
support the 
project. 
 
Coster, J. E., Turner, J. 
K., Bradbury, D., & 
Cantrell, A. (2017). Why 
do people choose 
emergency and urgent 
care services? A rapid 
review utilizing a 
systematic literature 
search and narrative 
synthesis. Academic 
Emergency Medicine, 
24(9), 1137-1149. 
doi:10.1111/acem.13220 
To identify 
patients’ 
reasons to 
visit urgent 
and 
emergency 
care 
 
38 studies 
from 
literature 
review 
between 
1995 and 
2016. 
Level III Systemic 
review with 
meta-analysis 
 
Identified 
reasons 
including 
unavailable 
primary clinic, 
perceived 
urgency, 
significant 
others’ 
recommendatio
n, convenience, 
and perceived 
need for 
emergency 
services. 
Rapid 
review. No 
suggestion 
for change 
Yes, this study 
supports that most 
ED patients tend 
to consider EDs 
are more 
convenient and 
accessible for 
those with low 
socioeconomic 
status.  
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Gift, T. L., & Hogben, 
M. (2016). Emergency 
department sexually 
transmitted disease and 
human 
immunodeficiency virus 
screening: Findings from 
a national survey. 
Academic Emergency 
Medicine, 13(9), 993–
996. 
doi:10.1197/j.aem.2006.0
4.017 
 
To analyze 
the screen 
rates of STD 
and human 
immunodefici
ency virus by 
ED providers 
compared 
with other 
settings’ 
providers 
(primary 
clinics, 
hospital 
ambulatory 
clinics, or 
other) 
 
3,838 
survey 
respondents 
 
Level VI Descriptive 
study 
ED providers 
were less 
screening for 
the STDs and  
human 
immunodeficien
cy virus 
Small 
sample size.  
 
Yes, the findings 
can be compared 
to this project. 
Eaton, S., Biggerstaff, 
D., Petrou, S., Osipenko, 
L., Gibbs, J., Estcourt, C. 
S., . . . Szczepura, A. 
(2019). Young people’s 
preferences for the use of 
emerging technologies 
for asymptomatic regular 
chlamydia testing and 
management: a discrete 
choice experiment in 
England. BMJ Open, 
9(1):e023663. 
doi:10.1136/bmjopen-
2018-023663 
To assess the 
preference 
test options 
and treatment 
of 
asymptomatic 
chlamydia 
1230 young 
people aged 
16–24 years  
Level IV mixed methods 
design  
The strongest 
preference 
factors were 
chlamydia test 
accuracy and 
followed by 
time to result. 
The highest 
preference for 
remote 
chlamydia 
testing options 
are self-testing, 
self-sampling 
This study 
used an 
online panel 
that could 
limit 
generalizabil
ity because 
only 1,230 
young 
people 
responded to 
questionnair
es.  
Yes, the findings 
would be a good 
resource to apply 
to increase 
screening 
according to 
people’s 
preference. 
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and postal 
testing.  
Baird, J., & Merchant, R. 
C. (2014). A randomized 
controlled trial of the 
effects of a brief 
intervention to increase 
chlamydia and gonorrhea 
testing uptake among 
young adult female 
emergency department 
patients. Academic 
Emergency Medicine, 
21(12), 1512-1520. 
doi:10.1111/acem.12539. 
To evaluate 
the effect of a 
brief 
educational 
and 
counseling 
intervention 
on increasing 
the STD 
testing among 
asymptomatic 
young female 
ED patients. 
171 women, 
a 
convenience 
sample of 
aged 18-35 
years in two 
EDs 
 
Level I 
RCT 
A randomized 
controlled trial. 
Offered a brief 
educational and 
counselling 
intervention 
48% in the 
brief 
intervention 
group accepted 
testing while 
36% in the 
control group 
accepted 
testing. The 
chlamydia 
positivity rate 
was 7%.  
Small 
sample, a 
convenience 
sample (not 
randomly 
selected 
from the ED 
population) 
Yes, most 
women who are 
infected with 
chlamydia appear 
asymptomatic. 
Screening is an 
important 
strategy in 
preventing the 
sequelae of 
untreated 
chlamydial 
infection.  
Gottlieb, S. L., Xu, F., & 
Brunham, R. C. (2013). 
Screening and treating 
Chlamydia trachomatis 
genital infection to 
prevent pelvic 
inflammatory disease: 
interpretation of findings 
from randomized 
controlled trials. Sexually 
Transmitted Diseases, 
40(2), 97-102. 
doi:10.1097/OLQ.0b013
e31827bd637 
To analyze 
randomized 
controlled 
trial findings 
(secondary 
data analysis) 
Six 
randomized 
trial 
research 
review 
Level I Systemic 
review with 
RCTs and meta-
analysis 
Chlamydia 
screening and 
treatment is a 
positive 
intervention to 
reduce the risk 
of PID 
Uncertain of 
timing of 
PID relative 
to screening,  
 
Yes, screening 
strategy would be 
more enhanced to 
prevent PID.  
 
Goyal, M. K., Witt, R., 
Hayes, K. L., Zaoutis, T. 
E., & Gerber, J. S. 
(2014). Clinician 
To examine 
physician 
adherence to 
guidelines for 
1000 
randomly 
selected 13- 
to 19-year-
Level 
IV 
Retrospective, 
cross-sectional 
study 
Pediatric 
primary care 
physicians 
infrequently 
No 
control/inter
vention 
group 
Yes, these 
findings support 
physicians’ 
nonadherence to 
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adherence to 
recommendations for 
screening of adolescents 
for sexual activity and 
sexually transmitted 
infection/human 
immunodeficiency virus. 
The Journal of 
Pediatrics,165(2), 343-
347. 
doi:10.1016/j.jpeds.2014.
04.009 
documentatio
n of sexual 
history and 
screening for 
STD. 
old routine 
well visits 
document 
sexual histories 
and practice 
STD screening 
CDC guideline 
for chlamydia 
screening.  
Jenkins, W. D., Zahnd, 
W., Kovach, R., & 
Kissinger, P. (2013). 
Chlamydia and 
gonorrhea screening in 
United States emergency 
departments. The Journal 
of Emergency Medicine, 
44(2), 558-567. 
doi:10.1016/j.jemermed.
2012.08.022  
To evaluate 
the prevalence 
of CT/GC 
infection in 
ED patients 
assessing the 
treatment and 
effect of ED 
screening 
 
42 articles 
from 1995 
to 2010 
Level III 
 
Systemic 
review with 
meat-analysis  
Posotive rates 
of STDs is high 
and are in the 
high-risk 
populations in 
ED. 
Exclusion of 
non-English 
-speaking 
nations 
Yes, educating 
ED providers on 
the topics of 
chlamydia 
epidemiology, 
sample collection, 
and analysis will 
enable them to 
address the risks 
in their presenting 
populations. 
Kreisel, K., Flagg, E. W., 
& Torrone, E. (2017). 
Trends in pelvic 
inflammatory disease 
emergency department 
visits, United States, 
2006–2013. American 
Journal of Obstetrics and 
Gynecology, 218(1), 117 
e1-117 e10. 
To assess the 
prevalence of 
PID in ED 
 
Data from 
HCUP 
NEDS; 
during 
2006–2013, 
25.7 million 
to 31.0 
million 
annual ED 
Level 
III 
Systemic 
review with 
meta-analysis 
 
A percentage of 
ED visits with 
low income, no 
insurance, 
public health 
because of PID 
increased 
during 2006–
2013 while the 
episode of ED 
No single 
test or 
laboratory-
based 
diagnosis, 
but mostly 
rely on 
clinical signs 
and 
symptoms. 
Yes, the lower 
incidence of the 
PID would have 
related to increase 
STD screening 
effort.  
 
ASYMPTOMATIC CHLAMYDIA SCREENING 50 
 
doi:10.1016/j.ajog.2017.
10.010 
visits from 
24–30 states 
visit with PID 
in females aged 
15-44 years 
decreased.  
As a result, 
the PID can 
be diagnosed 
by 
physicians’ 
subjective 
practice. 
Lunny, C., Taylor, D., 
Hoang, L., Wong, T., 
Gilbert, M., Lester, R., . . 
. Ogilvie, G. (2015). 
Self-collected versus 
clinician-collected 
sampling for chlamydia 
and gonorrhea screening: 
A systemic review and 
meta-analysis. PLoS 
One, 10(7):e0132776. 
doi:10.1371/journal.pone
.0132776 
 
To compare 
self-collected 
vaginal, urine, 
pharyngeal 
and rectal 
samples at 
home-based 
to providers 
collected 
cervical, 
urethral, 
pharyngeal 
and rectal 
sampling 
techniques at 
clinical 
settings  
21 studies 
based on 
over 6100 
paired 
samples 
 
Level 
III 
Systemic 
review with 
meta-analysis 
The significant 
validity of 
vaginal self-
collected swabs 
compared to 
swabs collected 
by providers 
and of urine 
samples for 
men at home.  
 
No studies 
included 
internet-
based self-
collection, in 
rural area, 
and few 
studies 
addressed 
gonorrhea 
self-
collection. 
Yes, self-
screening would 
be increasing the 
rates of STDs 
screening. 
Menon, S., Timms, P., 
Allan, J. A., Alexander, 
K., Rombauts, L., 
Horner, P., . . . Huston, 
W. M. (2015). Human 
and pathogen factors 
associated with 
Chlamydia trachomatis-
related infertility in 
To analyze 
human-based 
evidence that 
relates 
chlamydia 
with 
reproductive 
pathologies in 
women 
Not 
applicable 
Level 
I 
Systemic 
literature review 
with RCTs 
 
Described that 
chlamydia 
genotypes, 
immune 
responses that 
sexual behavior, 
coinfections, 
and repeat 
infections are 
Not 
applicable 
Yes, this literature 
is a 
comprehensive 
review and would 
encourage to 
screening for at 
risk asymptomatic 
women. Supports 
that fact PID may 
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women. Clinical 
Microbiology Reviews, 
28(4). 969-985. 
doi:10.1128/CMR.00003
5-15.  
all likely to be 
resulted in 
development of 
infertility. 
develop infertility 
and chlamydia 
infection causes 
PID.  
 McKee, D. M., 
Alderman, E., York, D. 
V., Blank, A. E, Briggs, 
R. D., Hoidal, K. E. S., . . 
. Racine, A. D. (2018). A 
Learning Collaborative 
Approach to Improve 
Primary Care STI 
Screening. Clinical 
Pediatrics, 57(8), 895-
903. 
doi:10.1177/0009922817
733702 
To improve 
screening for 
sexual activity 
and sexually 
transmitted 
infections  
11 Bronx 
Ongoing 
Pediatric 
Screening 
(BOPS) and 
participating 
sites and 10 
non-
participating 
sites. 
Level II Well-designed 
control trials 
without 
randomization 
Screening at 
non–health care 
maintenance 
visits improved 
more at BOPS 
sites 
 
Less strong 
in internal 
validity 
because of 
non-
randomized 
Yes, this research 
was conducted in 
the Bronx, New 
York. The results 
would be the best 
resources to this 
student’s project.  
McNulty, C. A. M., 
Hogan, A. H., Ricketts, 
E. J., Wallace, L., Loiver, 
I., Campbell, R., . . . 
Charlett, A. (2013). 
Increasing chlamydia 
screening tests in general 
practice: a modified 
Zelen prospective cluster 
randomized controlled 
trial evaluating a 
complex intervention 
based on the theory of 
planned behavior. Health 
Services Research, 90(3). 
To assess 
effectiveness 
chlamydia 
screening 
intervention 
to general 
practitioners 
in England 
 
76 
intervention 
and 81 
control 
practices 
 
Level I Randomized 
controlled trial 
 
Doubled 
chlamydia 
screening rates 
 
Many 
components 
of the theory 
of planned 
behavior 
(TPB) 
interventions 
might not 
fully utilized 
as education 
interventions 
for a 
research. So 
the outcomes 
of another 
Yes, consistent to 
the benefit of 
intervention to 
chlamydia 
screening 
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doi:10.1136/sextrans-
2013-051029. 
similar 
research 
with TPB 
would be 
different.  
Morhason-Bello, I. O., 
Ojengbede, O. A.,  
Oladokun, A., 
Adedokun, B. O.,  Ajayi, 
A., Adeyanju, A. A., . . . 
Kareem, O. I. (2014). 
The prevalence and 
outcome of 
asymptomatic chlamydial 
infection screening 
among infertile women 
attending gynecological 
clinic in Ibadan, South 
West Nigeria. Annals of 
Medical and Health 
Science Research, 4(2), 
253-257. 
doi:10.4103/2141-
9248.129057 
To evaluate 
the 
relationship 
between an 
asymptomatic 
chlamydial 
infection and 
infertile 
women and 
hysterosalping
ogram (HSG). 
 
132 infertile 
women 
 
Level V Retrospective 
study 
 
Asymptomatic 
chlamydial 
infection is 
common among 
infertile women 
and it 
significantly 
predict HSG 
blockage. 
 
Small 
sample, short 
periods of 
infertile  
 
Yes, this study 
can be a 
significant 
evidence to treat 
chlamydia to 
prevent infertility. 
 
Operario, D., Wang, D., 
Zaller, N. D., Yang, M. 
F., Blaney, K., Cheng, 
K., . . . Coates, T.J. 
(2016). Effect of a 
knowledge-based and 
skills-based programme 
for physicians on risk of 
sexually transmitted 
To evaluate a 
knowledge-
based and 
skills-based 
programme 
for physicians 
in China to 
reduce 
249 
physicians 
(121 
physicians 
in the 
intervention 
group and 
128 in the 
Level I Clustered 
randomized trial 
Significant 
decrease of 
chlamydia 
reinfection rates 
in the 
intervention 
group 
 
Participants 
within a 
cluster might 
be treated 
similarly and 
have similar 
outcomes. 
As a result, 
the 
Yes, the 
educational 
intervention to 
physicians would 
increase the 
screening rate. 
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reinfections among high-
risk patients in China: a 
cluster randomized trial. 
Lancet Global Health, 
4(1), e29-36. 
doi:10.1016/S2214-
109X(15)00249-1. 
patients’ STI 
risk. 
 
control 
group) 
 
reliability 
and validity 
would have 
been 
affected. 
Phillipson, L., Gordon., 
R., Telenta, J., Magee, 
C., & Janssen, M. (2015). 
A review of current 
practices to increase 
chlamydia screening in 
the community – a 
consumer‐centered social 
marketing perspective.  
Health Expect, 19(1), 5-
25. 
doi:10.1111/hex.12337 
To assess 
effectiveness 
chlamydia 
screening 
interventions 
in young 
adults less 
than 30 years 
old in  
community 
setting (Social 
marketing 
benchmark 
criteria) 
30 full-text 
literature 
review 
 
Level III Systemic 
review with 
meta-analysis 
 
Social 
marketing 
benchmark 
intervention (a 
consumer-
centered 
approach to 
behavior 
change)  
resulted positive 
outcomes 
(increase 
screening rate) 
Quality of 
evidence 
was low 
Yes, benchmark 
criteria would be 
a good resources 
to utilize for 
implementation of 
intervention  
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Rivard, K. R., Dumkow, 
L. E., Draper, H. M., 
Brandt, L.K. L., Whalen, 
D. W., & Egwuatu, N. E. 
(2016). Impact of rapid 
diagnostic testing for 
chlamydia and gonorrhea 
on appropriate 
antimicrobial utilization 
in the emergency 
department. Diagnostic 
Microbiology and 
Infectious Disease, 87(2), 
175-179. 
doi:10.1016/j.diagmicrob
io.2016.10.019 
 
 
To evaluate 
the impact of 
chlamydia 
and gonorrhea 
rapid 
diagnostic 
testing (RDT) 
in an urban 
emergency 
department 
(ED) on 
treatment 
appropriatene
ss, time to 
notification, 
and cost. 
The 
traditional 
testing 
group and 
the RDT 
group 
consisted of 
200 
consecutive 
patients 
from 
December 
2013–
January 
2014. 
Level III A quasi‐
experimental 
study. 
The RDT group 
had a 
significant 
increase in 
treatment, faster 
notification for 
results, and cost 
savings. 
Conducted 
in only one 
single ED 
setting, small 
sample size 
Yes, the CT/GC 
test usually takes 
48-72 hours 
resulted in 
delaying to 
treatment positive 
patients and 
unnecessary 
antibiotics for 
negative patients. 
 
Lorch, R., Hocking, J., 
Temple-Smith, M., Law, 
M., Yeung A., Wood, A., 
. . . Guy, R. (2013). The 
chlamydia knowledge, 
awareness and testing 
practices of Australian 
general practitioners and 
practice nurses: Survey 
findings from the 
Australian chlamydia 
control effectiveness 
pilot (ACCEPt). BMC 
Family Practice, 
14(169). doi: 
Evaluate 
Chlamydia 
knowledge for 
increasing 
screening. 
General 
practitioners 
and 
practical 
nurses. 
Level II A randomized 
control trial. 
Gaps between 
chlamydia 
knowledge and 
practice. 
Difference 
chlamydia 
knowledge 
and interest 
between the 
general 
practitioners 
and practical 
nurses. 
General 
practitioners 
were 
recruited 
while 
practical 
Yes, the 
questionnaire 
used by this study 
would be 
resourceful to 
design a modified 
questionnaire for 
the project. 
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10.1186/1471-2296-14-
169 
 
 
 
 
 
 
 
nurses were 
randomized 
selected at 
the clinic 
that 
chlamydia 
screening is 
practiced. 
 
Pickett Pickett, M. L., 
Melzer-Lange, M. D., 
Miller. M. K., Menson, 
S., Vistocky, A. M., & 
Drendel, A. L. (2018). 
Physician adherence to 
CDC guidelines for 
sexually active 
adolescents in the 
pediatric emergency 
setting. Pediatric 
Emergency Care. 34(11), 
767-773. doi; 
10.1097/PEC.000000000
0000873 
 
To evaluate 
physicians’ 
adherence to 
CDC 
guidelines for 
CT/GC, 
physicians’ 
characteristics 
related to 
guideline 
adherence, 
and 
physicians’ 
knowledge of 
expedited 
partner 
therapy 
(EPT).  
 
A 257 
physician 
among 
members of 
the 
American 
Academy of 
Pediatrics 
(AAP) 
Section of 
ED. 
 
Level IV 
 
A descriptive 
sturdy, cross-
sectional, 
anonymous, 
Internet-based 
survey tool 
 
ED providers; 
62.4% females, 
46.0% less than 
seven years 
working in EDs, 
86.2% in 
academic 
medicine. 
85.6% of 
participants 
adhered to 
CT/GC 
screening for 
asymptomatic 
patients in CDC 
guidelines. 
30.4% of 
physicians 
responded about 
state EPT law 
knowledge. 
The survey 
was only 
emailed to 
members of 
the AAP 
(biased 
sample) 
 
Yes, the study 
seems a good 
resource to 
enhance the 
current guidelines 
to the ED 
providers to 
improve 
screening.  
 
Keegan, M. B., Diedrich, 
J. T., & Peipert, J. F. 
(2014). Chlamydia 
To review 
current 
criteria and 
2 RCTs 
literature 
review 
Level I 
 
Systemic 
reviews with 
RCTs 
Screening 
for chlamydia 
for women age 
Limited data 
for men for 
routine 
Yes, current 
screening 
recommendations 
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trachomatis infection: 
Screening and 
management. Journal of 
Clinical Outcomes 
Management, 21(1), 30-
38. Retrieved from 
https://www.ncbi.nlm.nih
.gov/pmc/articles/PMC42
79217 
rationale 
for Chlamydia 
trachomatis s
creening, 
testing 
methods, and 
treatment of 
infection. 
 
25 and younger 
and men and 
women of 26 
and older at 
increased risk 
identifies for 
the early 
treatment of 
disease, 
avoiding 
sequelae of 
untreated 
chlamydial 
infection such 
as PID, ectopic 
pregnancy, and 
reducing health 
care costs. 
chlamydia 
screening 
should be 
practiced in EDs 
as CDC 
guidelines 
Tamarelle, J., Thiébaut, 
A. C. M., Sabin, B., 
Bébéar, C., Judlin, P., 
Fauconnier, A., . . . 
Delarocque-Astagneau, 
E. (2017). Early 
screening 
for chlamydia in young 
women for primary 
prevention of pelvic 
inflammatory disease (i-
Predict): Study protocol 
for a randomized 
controlled trial. Europe 
PMC, 18(1), 534. 
To screening 
and treatment 
for chlamydia 
in young 
women less 
than 25 years 
of age in 
France 
reduces the 
incidence of 
PID over 
24 months.eva
luate whether 
early  
 
4000 
sexually 
active 
female 
students 
under 25 
years old 
enrolled at 
five 
universities 
in France 
 
Level I Randomized 
prevention trial; 
experimental 
group’s vaginal 
home swab 
samples will be 
tested and 
treated 
immediately 
according to the 
positive results. 
Control group’s 
vaginal home 
swab samples 
will be delayed 
The study 
protocol will be 
implanted with 
the results of 
the incidence of 
first PID over 
24 months in 
the 
experimental 
group’s and in 
the control 
group’s 
measurement of 
duration of 
chlamydia 
Ethical 
issues for 
control 
group’s 
deferred 
chlamydia 
analysis of 
collected 
vaginal 
samples at 
first. No 
actual results 
found in the 
study. 
Yes, this study 
would support 
chlamydia 
screening as a 
strategy to lower 
the rate of PID. 
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until the end of 
the study 
period.  
 
infection at 6 or 
12 or over 18 
months. 
The 
estimated 
primary 
analysis 
completion 
date is 
October 
2021. 
Tibbits, M., Maloney, S., 
Ndashe, T., Grimm, B., 
Johansson, P., & 
Siahpush, M. (2018). 
Impact of the 
community-wide 
adolescent health project 
on sexually transmitted 
infection testing in 
Omaha, Nebraska. 
American Journal of 
Public Health, 108(6), 
782-784. 
doi:10.2105/AJPH.2018.
304391  
 
To evaluate 
the 
effectiveness 
of Adolescent 
Health Project 
 (media 
campaigns 
and free STI 
testing) to 
STD 
screening rate  
 
Young 
women 
(64%), and 
almost half 
were 
performed 
among 
young 
people 15 to 
24 years of 
age (46%), 
ethnicity 
(Hispanic, 
34%,; 
White, 31%; 
African 
American, 
25%; and 
other 
racial/ethnic 
groups, 
10%). 
Level IV Prospective 
study 
Significant 
increase STD 
screening rates 
during the 
phase 2 (free 
STI testing). 
 
No control 
groups 
Yes, the outcomes 
suggested that 
free STD testing 
and education 
through media 
campaigns would 
increase screening 
among young 
people and adults. 
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Schneider, K., 
FitzGerald, 
M., Byczkowski, T., & 
Reed J. (2016). 
Screening for 
asymptomatic gonorrhea 
and chlamydia in the 
pediatric emergency 
department. Sexually 
Transmitted Disease, 
43(4), 209-215. 
doi:10.1097/OLQ.00000
00000000424. 
To evaluate 
the prevalence 
of CT/GC in 
asymptomatic 
adolescents 
and barriers to 
STD 
screening. 
 
A 
convenience 
sample, 719 
participants 
(68% of 
approached 
participated)
, aged 14-21 
in an urban 
ED 
 
Level IV 
 
Cross sectional 
and descriptive 
study 
 
40 participants 
(9.8%) tested 
positive for an 
STD. the main 
barrier to STD 
screening was 
patient-
perceived lack 
of risk. 
A 
convenience 
sample, only 
68% 
participated 
Yes, the findings 
justify the CDC 
recommendations. 
 
Redgrove, K. A., & 
McLaughlin, E. A. 
(2014). The role of the 
immune response in 
Chlamydia Trachomatis 
infection of the male 
genital tract: A double-
edged sword. Frontiers 
in Immunology, 5(534). 
doi:10.3389/fimmu.2014.
00534 
To examine 
the effect of 
persistent 
chlamydia 
infection to 
the male 
genital tract. 
 
Not 
applicable 
(Literature 
review) 
Level V Systemic 
review, 
descriptive 
study 
Chronic 
chlamydia 
infection can 
damage the 
male 
reproductive 
tract resulting 
infertility. 
 
No 
intervention, 
no samples. 
Yes, good 
theoretical work 
to support the 
project. 
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Appendix C 
Pre-Education Questionnaire 
A. Characteristic 
Sex Female Male 
  
Age group <30 years  
30-49 years  
>50 years  
Years experienced in the  
ED 
 <2 years  
2-5 years   
>5 years  
B. Statistics  
Which borough has the 
highest number of 
chlamydia in New York 
Bronx  
Brooklyn  
Manhattan  
Queens  
Staten Island  
Which age groups have 
the highest rates of 
chlamydia infection in 
women 
 
Aged 15-19 years  
Aged 20-24 years  
>25 years  
Most chlamydia 
infections are 
asymptomatic in women 
Yes  
No  
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C. According to the CDC guidelines 2015, chlamydia 
Annual screening is 
recommended to sexually 
active women under 25 
years of age 
Yes  
No  
Annual screening is 
recommended to 
sexually active women 
aged 25 years old if an 
increased risk 
Yes  
No  
Retest approximately 3 
months after treatment 
Yes  
No  
Treatment of chlamydia 
with a single I g dose of 
azithromycin or 
doxycycline 100 mg 
twice a day 
Yes  
No  
Chlamydia alternative 
regimens are 
Erythromycin, 
Levofloxacin, or 
Ofloxacin 
Yes  
No  
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Appendix D 
Post-Education Questionnaire 
A. Statistics  
Which borough has the 
highest number of 
chlamydia in New York 
Bronx  
Brooklyn  
Manhattan  
Queens  
Staten Island  
Which age groups have 
the highest rates of 
chlamydia infection in 
women 
Aged 15-19 years  
Aged 20-24 years  
>25 years  
Most chlamydia 
infections are 
asymptomatic in women 
Yes  
No  
B. According to the CDC guidelines 2015,  chlamydia 
Screening is 
recommended to sexually 
active women under 25 
years of age 
Yes  
No  
Screening is 
recommended to 
sexually active women 
aged 25 years old if an 
increased risk 
Yes  
No  
Retest approximately 3 
months after treatment 
Yes  
No  
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Treatment of chlamydia 
with a single I g dose of 
azithromycin or 
doxycycline 100 mg 
twice a day 
Yes  
No  
Chlamydia alternative 
regimens are 
Erythromycin, 
Levofloxacin, or 
Ofloxacin 
Yes  
No  
C. Possible barriers 
Over treating  
Time constraints  
Religion/ethnicity  
Did not know the CDC 
guidelines 
 
Others  
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Appendix E 
Collaborative Institutional Training Initiative Certificate 
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Appendix F 
A Letter of Support from the Organization 
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Appendix G 
Copy of Institutional Review Board Approval Letter 
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Appendix H 
Post-Education Intervention Questionnaire (PEIQ) 
Chlamydia screening (CDC guidelines, 2015) for asymptomatic patients 
             Routine annual screening for sexually active women and for all pregnant women 
under 25 years of age  
    
Others;         Women including pregnant older than 25 who are at risk (women who have 
new, multiple sexual partners, and history of chlamydia) 
                          Men in high prevalence clinical settings, and MSM 
1. If a female patient who is sexually active and younger than 25 years old had no 
symptoms associated with chlamydia/GC, would you still order STD screen? 
 
1) Yes 
2) No 
3) Yes, if I remember the CDC guidelines 
 
2. If no, would you please answer the question why you don’t order STDs even though 
the CDC guideline recommends to screen for female asymptomatic patients who are 
younger than 25 years old? 
 
1) The patient is asymptomatic 
2) Not necessary based on my professional decision 
3) Unaware of the CDC guidelines 
4) No time; too busy 
5) Wasting time/money 
6) I don’t want to order 
7) ER is not the right place, may be GYN/Primary clinic 
8) A patient has conditions more serious than chlamydia 
9) Others 
 
10 If an asymptomatic patient has a history of positive STDs, are you going to screen? 
 
1) Yes 
2) No 
 
 
